SSRV and Associates resigns as Tavexia Lifecare statutory auditor

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • M/s. SSRV and Associates resigned as statutory auditor effective September 7, 2026
  • Cited preoccupation with other professional assignments and workload constraints
  • Firm was appointed on September 30, 2023, for a five-year term
  • Last limited review report submitted on August 4, 2026, for quarter ended June 30, 2026
  • No reportable concerns were raised with the Audit Committee prior to resignation
powered bylight_fuzz_icon
50335828

*this image is generated using AI for illustrative purposes only.

Tavexia Lifecare Limited (formerly Sattva Sukun Lifecare Limited) announced that M/s. SSRV and Associates has resigned as its statutory auditor with immediate effect on September 7, 2026.

The chartered accountancy firm cited preoccupation with other professional assignments and workload constraints as the reason for stepping down. The resignation was communicated to the Board of Directors via a letter dated September 7, 2026.

Auditor Tenure and Transition

SSRV and Associates was originally appointed as the statutory auditor on September 30, 2023. The Board of Directors had approved their reappointment for a second term of five consecutive years in August 2023, covering the period until the conclusion of the 48th Annual General Meeting.

The firm submitted its latest limited review report for the quarter ended June 30, 2026, on August 4, 2026. This filing occurred approximately one month prior to the resignation notification.

Regulatory Disclosures

In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Tavexia Lifecare filed the intimation with the Bombay Stock Exchange. The disclosure aligns with Part A of Schedule III of the regulations and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026.

The auditor confirmed there were no reportable concerns requiring communication to the Audit Committee or the Board prior to resignation. Consequently, no such communication was made during the tenure.

Particulars Details
Auditor Name M/s. SSRV and Associates
Date of Resignation September 7, 2026
Reason Professional commitments and workload
Appointment Date September 30, 2023
Last Report Filed August 4, 2026 (Q2 FY27 limited review)

SSRV and Associates issued a No Objection Certificate (NOC) allowing the company to appoint a new eligible auditor to fill the casual vacancy. The company is required to complete applicable statutory filings with the Registrar of Companies and stock exchanges.

Historical Stock Returns for Sattva Sukun Lifecare

1 Day5 Days1 Month6 Months1 Year5 Years
+3.92%+4.95%+43.24%+41.33%+27.71%0.0%

How quickly can Tavexia Lifecare appoint a replacement auditor, and could the vacancy create delays in upcoming financial reporting deadlines?

Does the mid-term resignation of SSRV and Associates raise any governance concerns for investors, particularly given the company's recent rebranding from Sattva Sukun Lifecare?

What impact could the auditor transition have on Tavexia Lifecare's ability to meet regulatory filing requirements with the Registrar of Companies and BSE within stipulated timelines?

like17
dislike

Sattva Sukun promoter group sells 14 lakh shares on market

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Roshan Dealmark Pvt Ltd sold 14,00,000 equity shares of Sattva Sukun Lifecare on September 3, 2026
  • The promoter group's consolidated stake fell from 6.39% to 6.02% post-transaction
  • Total shares held by the group now stand at 2,31,29,777
  • The company, now named Tavexia Lifecare Limited, maintains a paid-up capital of ₹38,36,01,248
powered bylight_fuzz_icon
50307941

*this image is generated using AI for illustrative purposes only.

The promoter group of Sattva Sukun Lifecare has reduced its stake in the company following an on-market share disposal. Roshan Dealmark Private Limited sold 14,00,000 equity shares on September 3, 2026.

This transaction brings the consolidated holding of the promoters and persons acting in concert to 2,31,29,777 shares, representing 6.02% of the total voting capital. The disposal was made pursuant to Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 and Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Transaction Details

Roshan Dealmark Private Limited, a key entity within the promoter group alongside Puja Agarwal, executed the sale entirely through on-market mechanisms. Prior to this transaction, the group held 2,45,29,777 shares, accounting for 6.39% of the company’s paid-up capital. The company, formerly known as Sattva Sukun Lifecare Limited, is now listed as Tavexia Lifecare Limited on the Bombay Stock Exchange.

Metric Before Disposal Disposal After Disposal
Shares Held 2,45,29,777 14,00,000 2,31,29,777
Stake (%) 6.39% 0.36% 6.02%

The paid-up capital of Tavexia Lifecare Limited remains unchanged at ₹38,36,01,248, comprising 38,36,01,248 equity shares of ₹1 each. There were no encumbrances or pledges associated with the shares held by the promoter group before or after the transaction.

What the Numbers Show

The reduction in stake is concentrated solely within Roshan Dealmark Private Limited. While Roshan Dealmark’s holding decreased by 14,00,000 shares to 2,30,49,777, the holding of Puja Agarwal remained static at 80,000 shares. This indicates a targeted liquidity event for the corporate promoter entity rather than a broad-based exit by all promoter group members.

Historical Stock Returns for Sattva Sukun Lifecare

1 Day5 Days1 Month6 Months1 Year5 Years
+3.92%+4.95%+43.24%+41.33%+27.71%0.0%

What strategic rationale might drive Roshan Dealmark Private Limited to liquidate shares while Puja Agarwal maintains a static holding?

How could this 0.37% reduction in promoter stake influence retail investor sentiment and short-term trading volume for Tavexia Lifecare?

Are there indications that this disposal is part of a broader, phased exit strategy by the corporate promoter entity or merely a portfolio rebalancing?

like15
dislike

More News on Sattva Sukun Lifecare

1 Year Returns:+27.71%